- Home
- ZEPP vs TLPH Comparison
ZEPP vs TLPH Comparison
Compare ZEPP & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZEPP | TLPH |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6M | 54.5M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ZEPP | TLPH |
|---|---|---|
| Price | $2.81 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.13 |
| AVG Volume (30 Days) | 70.4K | ★ 77.5K |
| Earning Date | 11-22-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $14.24 | N/A |
| Revenue Next Year | $6.50 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.15 | $0.69 |
| 52 Week High | $32.85 | $1.57 |
Technical Indicators
Market Signals| Indicator | ZEPP | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 27.98 |
| Support Level | $2.19 | $0.74 |
| Resistance Level | $5.57 | $0.89 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 77.22 | 25.63 |
Price Performance
Historical ComparisonAbout ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.